Skip to main content
Advertisement
Advertisement

HROW

HROW logo

Harrow, Inc. Common Stock

33.60
USD
Sponsored
-0.85
-2.47%
Sep 23, 15:59 UTC -4
Closed
exchange

After-Market

33.63

+0.02
+0.07%

HROW Earnings Reports

Positive Surprise Ratio

HROW beat 12 of 35 last estimates.

34%

Next Report

Date of Next Report
Nov 09, 2026
Estimate for Q3 26 (Revenue/ EPS)
$101.05M
/
$0.23
Implied change from Q2 26 (Revenue/ EPS)
+43.00%
/
-150.00%
Implied change from Q3 25 (Revenue/ EPS)
+41.05%
/
+4.55%

Harrow, Inc. Common Stock earnings per share and revenue

On Aug 10, 2026, HROW reported earnings of -0.46 USD per share (EPS) for Q2 26, missing the estimate of -0.18 USD, resulting in a -150.54% surprise. Revenue reached 70.66 million, compared to an expected 71.75 million, with a -1.52% difference. The market reacted with a -3.15% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 8 analysts forecast an EPS of 0.23 USD, with revenue projected to reach 101.05 million USD, implying an decrease of -150.00% EPS, and increase of 43.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Champions Oncology, Inc.
Report Date
Sep 10, 2026 For Q1 27
Estimate
-$0.01
Actual
-$0.03
Surprise
-194.12%
logo
PharmaCyte Biotech, Inc. Common Stock
Report Date
Sep 14, 2026 For Q1 27
Estimate
-
Actual
-$0.54
Surprise
-
FAQ
For Q2 2026, Harrow, Inc. Common Stock reported EPS of -$0.46, missing estimates by -150.54%, and revenue of $70.66M, -1.52% below expectations.
The stock price moved down -3.15%, changed from $40.70 before the earnings release to $39.42 the day after.
The next earning report is scheduled for Nov 09, 2026.
Based on 8 analysts, Harrow, Inc. Common Stock is expected to report EPS of $0.23 and revenue of $101.05M for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement